14 August 2014
New findings, published in the Cancer Research journal, suggest that taking nonsteroidal anti-inflammatory drugs (NSAIDs) could be beneficial for obese or overweight breast cancer patients.
Researchers have determined that combining these drugs, such as aspirin or ibuprofen, into their hormone therapy as part of their treatment can significantly lower breast cancer recurrence rates and cause a sizable delay in time to cancer recurrence.
The retrospective analysis of human subjects and cell cultures led the researchers to determine that using NSAIDs reduces the recurrence rate of the most common form of breast cancer by 50 per cent and extends the period of being disease free by more than two years.
ER positive - the most common form of breast cancer - accounts for around 75 per cent of all diagnoses and grows in response to exposure to estrogen.
Cancer researcher Linda deGraffenried of the University of Texas at Austin designed the study and cautioned that these results were preliminary but said: "We believe that obese women are facing a different disease. There are changes at the molecular level. We seek to modulate the disease promoting effects of obesity."
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.